Yasuaki Uemoto1, Megumi Uchida2, Naoto Kondo3, Yumi Wanifuchi-Endo1, Takashi Fujita1, Tomoko Asano1, Tomoka Hisada1, Sayaka Nishikawa1, Yusuke Katagiri1, Mitsuo Terada1, Akiko Kato1, Katsuhiro Okuda4, Hiroshi Sugiura5, Satoshi Osaga6, Tatsuo Akechi2, Tatsuya Toyama1. 1. Department of Breast Surgery, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan. 2. Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan. 3. Department of Breast Surgery, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan. nkondo@med.nagoya-cu.ac.jp. 4. Departments of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan. 5. Department of Education and Research Center for Advanced Medicine, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan. 6. Clinical Research Management Center, Nagoya City University Hospital, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, Japan.
Abstract
BACKGROUND: Although chronic postsurgical pain (CPSP) after breast cancer surgery is a common and prevalent postsurgical adverse event, the need for CPSP treatment has not been investigated. This study examined the proportion of patients who needed treatment for CPSP and associated predictors. METHODS: We conducted a cross-sectional study with female patients who underwent breast cancer surgery at our institution. Participants were aged ≤ 65 years at the time of this study and were at least 1 year post surgery. The questionnaire examined the presence of and need for treatment for CPSP and included the Japanese version of the Concerns about Recurrence Scale (CARS-J). Multivariate analyses were used to identify independent predictors of needing treatment for CPSP. RESULTS: In total, 305 patients completed the questionnaire. The mean time since surgery was 67.1 months; 156 (51%) patients developed CPSP after breast cancer surgery and 61 (39%) needed treatment for CPSP. Among patients that developed CPSP, the fear of breast cancer recurrence as assessed by the CARS-J (odds ratio [OR] 2.59, 95% confidence interval [CI] 1.14-6.28, P = 0.028) and ≥ 2 postsurgical pain regions (OR 2.52, 95% CI 1.16-5.57, P = 0.020) were independent predictors of needing treatment for CPSP. CONCLUSIONS: This study is the first to identify the proportion and predictors of patients who need treatment for CPSP. Fear of breast cancer recurrence and ≥ 2 postsurgical pain regions may predict the need for CPSP treatment among patients following breast cancer surgery.
BACKGROUND: Although chronic postsurgical pain (CPSP) after breast cancer surgery is a common and prevalent postsurgical adverse event, the need for CPSP treatment has not been investigated. This study examined the proportion of patients who needed treatment for CPSP and associated predictors. METHODS: We conducted a cross-sectional study with female patients who underwent breast cancer surgery at our institution. Participants were aged ≤ 65 years at the time of this study and were at least 1 year post surgery. The questionnaire examined the presence of and need for treatment for CPSP and included the Japanese version of the Concerns about Recurrence Scale (CARS-J). Multivariate analyses were used to identify independent predictors of needing treatment for CPSP. RESULTS: In total, 305 patients completed the questionnaire. The mean time since surgery was 67.1 months; 156 (51%) patients developed CPSP after breast cancer surgery and 61 (39%) needed treatment for CPSP. Among patients that developed CPSP, the fear of breast cancer recurrence as assessed by the CARS-J (odds ratio [OR] 2.59, 95% confidence interval [CI] 1.14-6.28, P = 0.028) and ≥ 2 postsurgical pain regions (OR 2.52, 95% CI 1.16-5.57, P = 0.020) were independent predictors of needing treatment for CPSP. CONCLUSIONS: This study is the first to identify the proportion and predictors of patients who need treatment for CPSP. Fear of breast cancer recurrence and ≥ 2 postsurgical pain regions may predict the need for CPSP treatment among patients following breast cancer surgery.
Authors: Li Wang; Jared C Cohen; Niveditha Devasenapathy; Brian Y Hong; Sasha Kheyson; Daniel Lu; Yvgeniy Oparin; Sean A Kennedy; Beatriz Romerosa; Nikita Arora; Henry Y Kwon; Kate Jackson; Manya Prasad; Dulitha Jayasekera; Allen Li; Giuliana Guarna; Shane Natalwalla; Rachel J Couban; Susan Reid; James S Khan; Michael McGillion; Jason W Busse Journal: Br J Anaesth Date: 2020-06-28 Impact factor: 9.166
Authors: Noud van Helmond; Hans Timmerman; Nick T van Dasselaar; Carmen C van de Pol; Soren S Olesen; Asbjorn M Drewes; Kris Vissers; Oliver H Wilder-Smith; Monique A Steegers Journal: Pain Physician Date: 2017-07 Impact factor: 4.965
Authors: Raafat M Reyad; Azza F Omran; Dina N Abbas; Mahmoud A Kamel; Ehab H Shaker; Jhon Tharwat; Ehab M Reyad; Tarek Hashem Journal: J Pain Symptom Manage Date: 2018-10-22 Impact factor: 3.612
Authors: Norbert Marschner; Tanja Trarbach; Jacqueline Rauh; Dirk Meyer; Sigrun Müller-Hagen; Johanna Harde; Stephanie Dille; Lisa Kruggel; Martina Jänicke Journal: Breast Cancer Res Treat Date: 2019-03-13 Impact factor: 4.872